1. Lowe H, Toyang N, Steele B, Bryant J, Ngwa W. The endocannabinoid system: A potential target for the treatment of various diseases. Int J Mol Sci 2021;22:9472.

2. Tanaka M, Sackett S, Zhang Y. Endocannabinoid modulation of microglial phenotypes in neuropathology. Front Neurol 2020;11:87.

3. Molina-Holgado F, Lledó A, Guaza C. Anandamide suppresses nitric oxide and TNF-α responses to Theiler’s virus or endotoxin in astrocytes. Neuroreport 1997;8:1929-1933.

4. Ilyasov AA, Milligan CE, Pharr EP, Howlett AC. The endocannabinoid system and oligodendrocytes in health and disease. Front Neurosci 2018;12:733.

5. Krishnan G, Chatterjee N. Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in Müller glia during inflammation. Glia 2012;60:1629-1645.

6. Krishnan G, Chatterjee N. Anandamide rescues retinal barrier properties in Müller glia through nitric oxide regulation. Neuroscience 2015;284:536-545.

7. Krishnan G, Chatterjee N. Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity. Mol Cell Neurosci 2014;59:10-23.

8. Mehraj V, Ramendra R, Isnard S, Dupuy FP, Lebouché B, Costiniuk C, et al. CXCL13 as a biomarker of immune activation during early and chronic HIV infection. Front Immunol 2019;10:289.

9. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010;11:597-610.

10. O’Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: The finetuners of Toll-like receptor signalling. Nat Rev Immunol 2011;11:163-175.

11. Sultan M, Alghetaa H, Mohammed A, Abdulla OA, Wisniewski PJ, Singh N, et al. The endocannabinoid anandamide attenuates acute respiratory distress syndrome by downregulating miRNA that target inflammatory pathways. Front Pharmacol 2021;12:644281.

12. Rahimian P, He JJ. HIV-1 Tat-shortened neurite outgrowth through regulation of microRNA-132 and its target gene expression. J Neuroinflammation 2016;13:247.

13. Doke M, Jeganathan V, McLaughlin JP, Samikkannu T. HIV-1 Tat and cocaine impact mitochondrial epigenetics: Effects on DNA methylation. Epigenetics 2021;16:980-999.

14. Doke M, McLaughlin JP, Cai JJ, Pendyala G, Kashanchi F, Khan MA, et al. HIV-1 Tat and cocaine impact astrocytic energy reservoirs and epigenetic regulation by influencing the LINC01133-hsa-miR-4726-5p-NDUFA9 axis. Mol Ther Nucleic Acids 2022;29:243-258.

15. Henry CJ, Huang Y, Wynne AM, Godbout JP. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokines. Brain Behav Immun 2009;23:309-317.

16. Huang Y, Henry CJ, Dantzer R, Johnson RW, Godbout JP. Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol Aging 2008;29:1744-1753.

17. Boehm M, Slack F. A developmental timing microRNA and its target regulate life span in C. elegans. Science. 2005;310:1954-1957.

18. de Lencastre A, Pincus Z, Zhou K, Kato M, Lee SS, Slack FJ. MicroRNAs both promote and antagonize longevity in C. elegans. Curr Biol. 2010;20:2159-2168.

19. Grillari J, Hackl M, Grillari-Voglauer R. miR-17-92 cluster: Ups and downs in cancer and aging. Biogerontology 2010;11:501-506.

20. Cambronero JC, Borrell J, Guaza C. Glucocorticoids modulate rat hypothalamic corticotrophin-releasing factor release induced by interleukin-1. J Neurosci Res 1989;24:470-476.

21. Fields JA, Swinton MK, Montilla-Perez P, Ricciardelli E, Telese F. The cannabinoid receptor agonist, WIN- 55212-2, suppresses the activation of proinflammatory genes induced by Interleukin 1 beta in human astrocytes. Cannabis Cannabinoid Res 2022;7:78-92.

22. Tzivion G, Dobson M, Ramakrishnan G. 2011. FoxO transcription factors; Regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta 2011;1813:1938-1945. 10